Serum S100B protein is increased in fasting rats

被引:55
作者
Netto, Cristina B. O.
Conte, Sabrina
Leite, Marina C.
Pires, Caroline
Martins, Tiago L.
Vidal, Penelope
Benfato, Mara S.
Giugliani, Roberto
Gonçalves, Carlos-Alberto
机构
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude Bioquim, Dept Bioquim, BR-90035003 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biofis, BR-90035003 Porto Alegre, RS, Brazil
[3] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90035003 Porto Alegre, RS, Brazil
[4] Hosp Clin Porto Alegre, Serv Genet Med, Porto Alegre, RS, Brazil
关键词
adipocytes; epinephrine; fasting; S100B; brain damage marker;
D O I
10.1016/j.arcmed.2005.11.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. S100B is a calcium-binding protein expressed and secreted by astrocytes; serum and cerebrospinal fluid (CSF) S100B elevation has been proposed as an index of brain damage. However, other tissues are shown to produce this protein and the clinical significance of serum S100B elevation has been discussed. Methods. We investigated the levels of serum and CSF S100B in fasting Wistar rats. Animals were divided into two groups, control and fasting for 48 h, and S100B levels in serum and CSF were determined by ELISA. S100B secretion in dissociated epididymal fat cells was investigated in the presence of epinephrine. Results. We observed a significant > 2-fold increase of S100B levels in serum of fasting rats, without changes in its CSF content. Moreover, we demonstrated in vitro epinephrine stimulated S100B release from fat cells. Conclusions. Present results reinforce that extracerebral sources of S100B, particularly adipocytes, contribute to its serum levels and support the idea that caution is needed when interpreting serum S100B increase as a clinical marker of brain damage. (c) 2006 IMSS. Published by Elsevier Inc.
引用
收藏
页码:683 / 686
页数:4
相关论文
共 29 条
[1]   Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sources [J].
Anderson, RE ;
Hansson, LO ;
Nilsson, O ;
Liska, J ;
Settergren, G ;
Vaage, J .
ANNALS OF THORACIC SURGERY, 2001, 71 (05) :1512-1517
[2]   IMMUNOHISTOCHEMICAL COLOCALIZATION OF S-100B AND THE GLIAL FIBRILLARY ACIDIC PROTEIN IN RAT-BRAIN [J].
BOYES, BE ;
KIM, SU ;
LEE, V ;
SUNG, SC .
NEUROSCIENCE, 1986, 17 (03) :857-865
[3]   IMMUNOCHEMICAL AND IMMUNO-CYTOCHEMICAL LOCALIZATION OF S-100 ANTIGEN IN NORMAL HUMAN-SKIN [J].
COCCHIA, D ;
MICHETTI, F ;
DONATO, R .
NATURE, 1981, 294 (5836) :85-87
[4]   Increase in serum S100B protein level after a swimming race. [J].
Dietrich, MO ;
Tort, AB ;
Schaf, DV ;
Farina, M ;
Gonçalves, CA ;
Souza, DO ;
Portela, LV .
CANADIAN JOURNAL OF APPLIED PHYSIOLOGY-REVUE CANADIENNE DE PHYSIOLOGIE APPLIQUEE, 2003, 28 (05) :710-716
[5]   S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles [J].
Donato, R .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (07) :637-668
[6]   On the release and half-life of S100B protein in the peripheral blood of melanoma patients [J].
Ghanem, G ;
Loir, B ;
Morandini, R ;
Sales, F ;
Lienard, D ;
Eggermont, A ;
Lejeune, F .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (04) :586-590
[7]  
HAIMOTO H, 1985, AM J PATHOL, V121, P185
[8]  
HAIMOTO H, 1987, LAB INVEST, V57, P489
[9]   Serum S100β increases in marathon runners reflect extracranial release rather than glial damage [J].
Hasselblatt, M ;
Mooren, FC ;
von Ahsen, N ;
Keyvani, K ;
Fromme, A ;
Schwarze-Eicker, K ;
Senner, V ;
Paulus, W .
NEUROLOGY, 2004, 62 (09) :1634-1636
[10]   S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma [J].
Hatpio, R ;
Einarsson, R .
CLINICAL BIOCHEMISTRY, 2004, 37 (07) :512-518